Doramectin
Functional Class: Anthelmintic agent
Search JECFA
Click the above link to access the relevant JECFA residue monograph(s)
Search WHO
Click the above link to access the relevant WHO evaluation
Maximum residue limits for Doramectin
Species
Tissue
MRL
Year of Adoption
Note
Muscle
10 µg/kg
1997
High concentration of residues at the injection site over a 35 day period after subcutaneous or intramuscular administration of the drug at the recommended dose.
Species
Tissue
Muscle
MRL
10 µg/kg
Year of Adoption
1997
Note
High concentration of residues at the injection site over a 35 day period after subcutaneous or intramuscular administration of the drug at the recommended dose.
Fat
150 µg/kg
1997
High concentration of residues at the injection site over a 35 day period after subcutaneous or intramuscular administration of the drug at the recommended dose.
Species
Tissue
Fat
MRL
150 µg/kg
Year of Adoption
1997
Note
High concentration of residues at the injection site over a 35 day period after subcutaneous or intramuscular administration of the drug at the recommended dose.
Milk
15 µg/kg
2006
Depending on the route and/or time of administration the use of doramectin in dairy cows may result in extended withdrawal periods in milk. This may be addressed in national/regional regulatory programmes.
Species
Tissue
Milk
MRL
15 µg/kg
Year of Adoption
2006
Note
Depending on the route and/or time of administration the use of doramectin in dairy cows may result in extended withdrawal periods in milk. This may be addressed in national/regional regulatory programmes.